VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 403 filers reported holding VANECK VECTORS ETF TR in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $98,000 | +6.5% | 2,511 | 0.0% | 0.03% | -2.9% |
| Q2 2020 | $92,000 | +58.6% | 2,511 | 0.0% | 0.03% | +25.9% |
| Q1 2020 | $58,000 | -21.6% | 2,511 | 0.0% | 0.03% | -6.9% |
| Q4 2019 | $74,000 | +10.4% | 2,511 | 0.0% | 0.03% | -9.4% |
| Q3 2019 | $67,000 | +4.7% | 2,511 | 0.0% | 0.03% | +6.7% |
| Q2 2019 | $64,000 | +14.3% | 2,511 | 0.0% | 0.03% | +15.4% |
| Q1 2019 | $56,000 | +5.7% | 2,511 | 0.0% | 0.03% | 0.0% |
| Q4 2018 | $53,000 | +12.8% | 2,511 | 0.0% | 0.03% | +4.0% |
| Q3 2018 | $47,000 | -16.1% | 2,511 | 0.0% | 0.02% | -13.8% |
| Q2 2018 | $56,000 | +1.8% | 2,511 | 0.0% | 0.03% | 0.0% |
| Q1 2018 | $55,000 | -5.2% | 2,511 | 0.0% | 0.03% | 0.0% |
| Q4 2017 | $58,000 | 0.0% | 2,511 | 0.0% | 0.03% | -3.3% |
| Q3 2017 | $58,000 | +5.5% | 2,511 | 0.0% | 0.03% | +7.1% |
| Q2 2017 | $55,000 | – | 2,511 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |